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ABSTRACT 
Concentration~ of gold in skin achieved during systemic chrysotherapy inhibited prosta-
glandin synthesis in vitro. using a sheep vesicular gland dioxygenase system. Two human 
epidermal enzymes, acid phosphatase and tryptophanyl · tRNA synthetase, were ah;o 
inhibited by gold in vitro. but at higher concentrat iom;; the latter action was blocked 
by 2 ·mercaptoethanol. Anticpithelial antibody titer, and immunoglobulin synthes is as 
determined by serial herpes simplex complement -fixing antibody titer, were unaffected by 
gold. Furthermore. gold concentrations in ;.kin did not correlate ''ith thP clinical activity of 
pemphigus. These findings suggest some possible mechani!ims of gold action in pemphigu~. 
such as interrupt ion of the inflammatory cycle and inhibit ion of s kin enzymes involved in 
blister formation . 
Chrysotherap.\ i:-. beneficial in the mana gement 
of some patients with pemphigus [1) and rheuma-
toid arthritis [2 4) although its mechanism(sl of 
action has not been fully elucidated . An under-
standing of the site and mode of action of gold in 
pemphigu;, might result in an impru,·ed trea tment 
schedule and the application of chrysotherapy to 
other dermatologk conditions . Accordingly. an 
experimental protocol was de~igned to determine 
the effects of gold on a number of biologic system~:.. 
everal hypotheses have been advanced which 
may explain the action of gold in pemphigus and 
rheumatoid arthritis [5- 7). Likely possibilities in · 
elude: (1) interruption of the inflammatory cycle 
by inhibition of pro~:.taglandin s:mthesis; (21 inhibi-
tion of skin enzymes responsible for blister forma -
tion ; ( :~) interference with antigen antibody com-
plex formation ; and (4) immunosuppres!:>ion. To 
test these considerations . we s tudied the effect!> of 
gold sodium thiomalate on: (1) sheep vesicular 
gland dioxygena!.e, an enzy me that func tions in 
the sequence of prostaglandin synthesis: (2) several 
sulfhydryl-containing enzymes. human epidermal 
acid phosphatase , and t rvptophanyl -t R;:\1 A synt he-
tase (8 ): (3) the antiepithel ia l antibody immuno-
fluorescent test; and 14) the synthesi, of immuno-
globulins, by comparing serum herpes s implex 
complement-fixing antibody titers before and dur-
ing chrysotherapy. Skin gold levels were also 
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measured to determine the relationshtp of the 
clin ical res pon!:>e of pemphigus to tissue gold con-
cent rat tOns. 
EXPERIMEl\TAL PROCEDL RES 
Eifert of gold on prostal(landrn synthests 
Sheep vesicular gland dioxygenase was assayed as 
described by Smith et al [9,10 ). Gold sodium thiomalatet 
(G'I'M} in final concentrations of0-66pM was present in 
the reaction mixture. Dioxygenase was prepared by 
homogenizing 50 mg of acetone powder of sheep vesicular 
gland (Upjohn) in 1 ml of0.1 M Tris- HCl (pH 8.5) with a 
Dounce ball ·type homogenizer. Dioxygenase [9) was 
activated by addmg sufficient 0.1 M phenol to the 
enzyme preparation so that the final concentration of 
phenol was 0.67 M. The mixture was maintained at room 
temperature for a minimum of 30 min prior to testing. 
Enzyme preparations and GTM were placed in the 
side of the electrode holder of an oxygen monitor and 
incubated for 0-7 min. Immediately thereafter, arachi-
donic acid (Lipid Organic Research) (20 pM frnal concen· 
tration) wa!. added to the mixture and the reaction rate 
(,.M/ min) determined by continuous measurement~ of 
oxygen uptake, using an oxygen electrode. Oxygen ab· 
sorption was measured wrth a Yellow Springs Instrument 
Company oxygen monitor \1odel 53 equipped with a 
Model 5801 bath assembly and attached to a Beckman 
Model 100f>02 Linear-Log.Ten-lnch Potentiometric Re-
corder. Reading~ were made using the percent transmit · 
Lance selling of the recorder. The oxidation of arachi · 
donie acid (20 : 4, n-6) by the phenol ·activated vesicular 
gland dioxygenase was determined by measuring oxygen 
absorption at a constant temperature of 30" "' 0.5°C. At 
the termination of each experiment (in the presence of 
GTM I soy bean lipoxygenase (Sigma) was added to the 
reacu on mtxture and the additional consumption of 
oxygen recorded 19). For purposes of control, the buffer, 
salirvlates, and tndomethacin were simtlarlv tested. To 
verify that oxygen uptake was directly relat~ to prosta-
t Gold sodium thiomalate was obtained commercially 
as Mvochr\'s tne from Merck . • harp & Dohme. 
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glandin synthesis, (1-"C]arachidonic acid (Applied 
Science Lab.) was incubated as described above. The 
solution was extracted by Folch mixture and subjected to 
the t-hin-layer chromatography as described by Smith 
and Lands [9]. 
Effect of gold on skin acid phosphata11e and 
tryptophanyl-t RNA syntheta11e actiuity 
Acid phosphatase was studied as a representative 
lysosomal hyd rolase that may function in blister forma-
tion [11]. Tryptophanyl -tRNA synthetase was studied 
because it is a human epidermal sulfhydryl enzyme that 
is available in near homogeneous form which allowed for 
direct analysis of kinetic experiments. 
Split-thickness skin specimens were removed from 
normal human volunteers with a Davol dermatome. 
Whole skin was homogenized with a glass glass homoge-
nizer in 10 mM citrate buffer, pH 5.0, at 2°C. containing 
0.19! Triton X- 100. The homogenate was centrifuged at 
10,000 x g for 30 min. 
Acid phosphatase activity in the supernatant fraction 
was determined by the met hod of Ohkowara et al [12] 
using p-nitrophenyl phosphate as substrate. Dose-related 
inhibition experiment~ were performed using increasing 
GTM concentrations (ranging from 10-1000 ~g/mll , and 
similar s tudies were done employing sodium thiomalate 
as a control. 
Human epidermal tryptophanyl-tRNA synthetase 
(850-fold purified) was assayed as previously described 
(13]. The variability of the assay technique is i5~. This 
enzyme catalyses a two-step reaction involving the acti-
vation of tryptophan to form enzyme-bound trypto-
phanyl adenylate with the release of pyrophosphate, and 
the transfer of activated tryptophan to tRNA "" to form 
Trp-tRNA. L[·3"C]-tryptophan (New England Nuclear 
Corporation) was purified as described previously [14] 
with spectrophotometric determination of its concentra-
tion [15]. Brewers' yeast tRNA (Schwarz Bioresearch ) 
contained 38 pmoles tR~A"" per A210 unit.§ lnhib,ition 
experiments with concentrations of gold ranging from 
1- 100 ~tg/ml were performed. The effects of20 and 50 mM 
2-mercaptoethanol (Kodak) on this system were investi-
gated using a concentration of GTM that produced 50% 
inhibition of enzyme activity in the absence of added 
thiol. Kinetic constants and patterns, using a 2-min 
assay as previously described ]16], were determined usmg 
an IBM 3i0 computer with the program of Hanson et al 
[17] based on the theory of Bliss and James [18[. 
Effect of gold on the antzepithelial antibody (AEA) 
immunofluorescent test 
Sera obtained from 5 patients with pemphigus were 
frozen at 20° until tested. AEA titers were determined 
as previously described with human skin , monkey esoph-
agus, or guinea-pig I ip as substrate [19]. 
Effect of gold on anttepithelial antibody titer. AEA-
positive pemphigus sera were diluted with: GTM: sod ium 
thiomalate (TM), prepared by treating thiornalic acid 
(Aldrich) with I M NaOH to a final pH of6.0; or, 10 mM 
pota!ls ium phosphate buffer, pH 7.2; and incubated at 
room temperature for 30 min . Final concentrations of 
GTM were 1 and 5 mg/ml , and 1, 5, 10, 50, 100, and 500 
~g/ml. Concentrations of TM were one-hal f those used 
with GTM since GTM is approximately 50'lo gold by 
§One A •• unit of tRNA has an A210 of 1.0 in a 1.0-cm 
optical patt when dissolved in 1.0 ml of5 mM K2HPO, . • 
mM K2HPO, at pH 6.9. 
weight. Dilutions were made with the above-named 
buffer. AEA titers of gold-treated, TM-treated , and 
buffer-treated sera were compared. 
Effect of gold on epidermal antigen. Monkey esopha-
gus tissue was incubated with GTM (5 mg/ml), TM (2.5 
mg/ml) , or phosphate buffer for 30 min at 37•c. These 
tissues were then used as substrates to determine AEA 
titers on sera of known positivity. 
Suitabilzt) of 1n vivo gold-treated skin as a substrate. 
Biopsies were obtained from normal -appearing skin of 2 
patients with pemphigus with negative AEA titers who 
had received a cumulative dose of 400 mg or more of 
GTM. These tissues served as suhstrates for AEA titer 
determination on sera of known positivity. 
Effect of gold on herpes simplex complement-fixzng 
antibody titer 
Herpes simplex complement -fixing antibody titers 
were assayed using standard techniques [20). Sera ob-
tained before and during chrysotherapy (500 mg cumula-
tive dose) were simultaneously assayed for herpes sim-
plex complement-fixing antibodies. 
Relationship of skin gold concmtration to course of 
pemphi11us 
Serial skin biopsies (3- 10 mg wet weight) were taken 
from uninvolved skin of 4 patients with pemphigus before 
and during chrysotherapy using a 4-mm punch. Tissue 
specimens were placed into acid-washed, preweighed 
0.9-ml polyethelene capsules and weighed on a Mettler 
balance. Capsules, with enclosed specimens, were dried 
for 6 hr under infrared heat lamps and tissue dry weight 
measured. Skin gold content was determined by neutron 
activation. Samples were irradiated at the 0.5 ng sensitiv-
ity level. Three blank capsules and 3 ashed fecal control 
specimens of known value were irradiated to serve as 
controls. 
RESl'LTS 
Effect of ~told on prostaglandin synthesi,~. The 
oxidation of arachidonic acid by sheep vesicular 
gland dioxygenase was inhibited by GTM in an 
instantaneous. concentration-dependent manner 
(Fig. 1). Addition of soy bean lipoxygenase at the 
termination of the inhibition experiment resulted 
in the generation of oxygen; GTM, therefore, did 
not interfere with the subst rat es in this reaction, 
but inhibited the dioxygenase specific for the 
transformation of a rachidonic acid into prosta-
glandin. Gold, in a final con central ion of 49 ~-tM , 
inhibited 50"! of dioxygenase activity, as calcu-
lated from a Dixon plot 121]. The inhibitory action 
of GTM was time-dependent , progressive loss of 
enzyme acti\'ity resulting from longer periods of 
incubation (Fig. 2). Buffer did not effect the 
svstem. Jn control experiments "C from arachi-
donic acid was incorporated into the PGE, frac-
tion. Aspirin and indomethacin, known prosta-
glandin dioxygenase inhibitors [10], produced sig-
nificant inhibition of activity. 
Effect of gold on skin acid phosphatase and 
tryptophanyl-tRNA syntheta.~e activity. GTM in-
hibited the activity of human epidermal acid 
phosphatase: equivalent concentrations of TM did 
not. The amount of inhibition was proportional to 
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Ftc. 1: ConcentratiOn-dependent inhibition of vesicu-
lar gland dioxygenase acttvity by GTM. Phenol-activated 
acetone powder of sheep vesicular gland was added to an 
assay mixture contaming 0.67 M phenol and the indi-
cated concentrations of GTM at 30°C. After ! -min 
exposure to mhibttor. arachidomc acid (20: 4. n-6. final 
concentration, 20 pM) was added and the reaction rate 
(pM/ min) determined from continuous measurements of 
oxygen uptake. Each point represents the mean of 5 
determination~ and as bracketed by ± l !:>tandard devaa-
tion . 
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FaG. 2: Time-dependent anhabition of vesicular gland 
dioxygenase by GTM. Phenol -activated acetone powder 
of sheep vesacular gland was mcubated with 33pM GTM 
(.t.) or no inhibitor COl for the indacated time periods at 
30°C. Arachidonic acid (20:4. n-6, final concentration, 20 
pM) was added to the mixture and the reaction rate 
determmed from the initial measurement of oxygen 
uptake. Each triangle represents the mean of 5 determi -
nations and is bracketed by ± l standard deviation . 
GTM concentration at concentrations less than 
500 1-1g/ml (Fig. :l). 
Similarly, purified human epidermal trypto-
phanyl-tRNA synthetase was inhibited by GTM 
(Fig. 4). The degree of mhibition was concentra-
tion-dependent and was prevented by 2-mercapto-
ethanol. Kinetic analy ·as demonstrated that GTM 
produced noncompetitive mhibition of all three 
substrates (ATP, tryptophan. tR:'-!A"P) !Fig. 51. 
Equivalent concentrations of TM had no effect 
upon enzyme acti\ tt}. 
Effect of GTM on AEA titer. AEA-posi tive sera 
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Fac. 3: Inhibition of human epidermal acid phospha-
tase actavaty by GTM . Epidermal homogenate was prein 
cubated for 5 min with increasing concentrations of 
GTM. Acad pho~phatase actidtv was determined as 
described under Expenmental Procedure;. Relative inhi-
bition is defined as the activaty remaining da,•aded by the 
acti\'lty of the untreated control. and is expressed as a 
percent . 
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FaG. -1 : lnhibauon of human epidermal tryptophanyl -
tR 'A synthetase by GTM. Aliquots of purified trypto-
phanyl -tR ' A wnthetase were preincubated for 5 min 
with increasing concentrations of GTM. Tryptophanyl -
tRNA synthetase activity was determmed as described 
under Expenmenta/ Procedures . Relative inhibition is 
defined as the actwity remammg divided by the activity 
of the untreated control, and is expressed as a percent 
were not affected by incubation with GTM. TM, or 
buffer; similarly, treatment of human skin and 
monkey esophagus subl'trates with the abo\'e 
ag-ents did not alter their abil it~ to serve as 
substrate~;. Human skin obtained from gold-
treated pemphigus patient!'. was al!'.o a satisfactory 
substrate for AEA titer determination 
Effect of pold on herp!'.~ simplex complement· 
f1:r.mp antLbody t1t er . Herpes simplex complement-
fixing nntibody titers did not change as a result of 
chrysot he rap\. There was no evidence of intercur-
rent herpes infectwn. T''o patient>< had identical 
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Fro. 5: Inh ibition of human epidermal tryptophanyl-
tRNA synthetase by GTM_ The reciprocals of the initial 
reaction velocities were plotted against the reciprocals of 
the molar concentrations ofL-tryptophan (A), ATP (B), 
or tR A"• (C) in the presence and absence ofGTM (0.1 
or 0.5 mg/ml). 
TABLE 
Skin gold content as a function of cumulative 
myochry.~ine dose 
km Au concentration Cumulatt\e 
l'attent (!<g/gml myochry~me dose 
Wet weight Orv weight !mg) 
SK 0.2 1.1 10 
0.9 2.6 110 
1.6 5.7 210 
2.8 5.7 360 
2.5 9.0 510 
4.3 14.0 610 
EA 0.1 0.3 0 
0.7 1.9 160 
4.1 8.6 460 
7.8 30.6 660 
LM 0 0 0 
0.8 L9 110 
4.2• 13.5 460 
2.6t 10_9 460 
TR 0 0 0 
1.5 LS 110 
3.6 6.9 610 
•t Skin biopsies taken from skin lesion• and unin -
volved skint at the time of lichen planus-like gold 
dermatitis. 
titers (l/8 to 1/8): 1 patient had an increase (1/4 to 
1/8). and 1 patient had a decrease of one dilution 
(l/16 to 1/8). 
Relationship of skin #Old concentration to the 
course of pemphi!!us. Skin gold content increased 
gradually during gold therapy (Table) [22]. There 
was no correlation, however. between quantity of 
gold in skin, cumulative dose of GTM, or activity 
of pemphi~us. 
DISClSSI0/10 
The results reported herein demonstrate that 
GTM affects several biologic systems of possible 
si~mificance in the pathogenesi!:. or perpetuation of 
pemphigus. The inhibition of prostaglandin syn-
thesis and human epidermal enzymes in vitro adds 
two additional, heretofore undescribed, mech-
anisms of action of gold to the list of its known 
effects . 
Previous studies suggest that certain prosta-
glandins may be important mediators of inflam-
mation, especially in some forms of arthritis [23, 
24] and dermatitis [25]. More recent work suggests 
that other prostaglandins may also have antiphlo-
gistic proper! ies [26]. While sal icylates and indo-
methacin, two anti-inllammatory agents useful in 
the management of some arthritic diseases, are 
potent inhibitors of prostaglandin synthesis, the 
effect of gold on prostaglandin synthesis was un-
known . The results of our studies indicate that 
GTM at therapeutic serum concentrations [27] 
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interferes with in vitro prostaglandin synthesis. 
Skin gold concentrations increased during chry-
sotherapy, and all patients attained levels of .J ~g 
elemental gold/gm skin wet weight. This corre-
sponds to an approximate concentration of 20 
nmoles/gm of GTM. Assuming that 1 gm wet 
weight of skm approaches 1 ml, GTM concentra-
tion in skin is 20 ~M. a level that mhibits prosta-
glandin synthesis in vitro (Fig. I). In a concomi-
tant experiment. Ziboh [28] demonstrated tha t 
GTM wa::; a more potent inhibitor of prostaglandin 
synthesis than salicylates. but was less potent than 
indomethacin . The effect of chrysotherapy on skin 
prostaglandins in vivo is presently under study. 
GTM inhibited two human epidermal enzymes, 
tryptnphanyl -t RNA synthetase and acid phospha-
tase, in vitro, an effect blocked by 2-mercaptoetha-
nol, a kncl\\ n prot ector of reduced sulfhydryl 
groups. Kinetic analy~is of the reaction between 
GTM and tryptophanyl-tR:\A synthetase demon-
strated noncompetit ive inh1bition. aturating 
quant itie::. of substrate failed to overcome the 
inhibition, suggesting irreversible complexing be-
tween gold and enzyme. The inhibitnry effects of 
gold on selected lysosomal enzymes in human 
synovial flu1d [29] and synovial fluid leukocytes 
[30] obtained from patient:; with RA have been 
reported previou I) . This IS the first time, however, 
that gold has been shown to inhibit human epider-
mal enzymes. Thui'-, gold may interact with en-
zymes throughout the body, presumably those 
having a reduced sulfhydryl group available for 
binding. This hypothesis receives additional in-
direct support from our earlier work demonstrating 
measurable quantities ol ~old in all hurpan tissues 
that were assayed [31J. Many lysosomal hydrolases 
are sulfhydryl enzymes (29), and may participate 
in acantholysis [11]. The beneficial effect of gold in 
pemphigus may relate, in part. to interference of 
blister formation by inhibition of degradative lyso-
somal enzymes such as acid phosphatase. 
The binding of AEA to epidermal antigen wa~ 
not altered by GTM at physiologic or pharmaco-
logic concentrations in vitro. De novo synthesis of 
antibody, as mea!-.ured by herpes simplex comple-
ment-fixing antibody titer. was not altered by gold 
administration in vivo. Reduced AEA titers in 
patients receiving chrysotherapy may be an effect 
of gold on diseast> activity with concomitant titer 
change, rather than a direct effect on AEA. Thus, 
AEA may be a secondary phenomenon in pem -
phigus, antibodies forming against released epider-
mal products from damaged skin. Clinical data 
suggest that reduct ion of AEA titers precedes 
clinical response (II]; this may represent an early 
response to decrea~ed antigen relea::;e. 
Attempt~ to correlate skin gold concentration 
with the clinical response of pemphigu!:> to chry-
sotherapy were unrewardmg. Gold was measured 
in whole skin specimens containing unspecified 
amounts of dermis Other work [22] ha indicated 
that keratinous t 1ssue~ have little affinity for gold, 
in contrast to other hea\'Y metals such as lead and 
arsenic. 
ln s ummary . we have attempted to define the 
mode:; of act ion of gold. In vitro gold in therapeutic 
serum concentrations has been found to inhibit 
prostaglandin synthesis and two epidermal en-
zymes. but had no effect on immunoglobulin 
synthesis or on the interaction of AEA with epider-
mal antigen. The results of our study suggest that 
the final biologic effect of gold in pemphigus may 
represent a combination of several mechanism!> of 
action. both at a local and systemic level. 
Note Added in Proof: 
We wish to thank the editor for directing our 
attention to an article (Deby C, Bacq Z-M, Simon 
D: In vitro inhibition of the biosynthesis of a 
prostaglandin by gold and silver. Biochem Phar-
macol 22:~141-3243, 1973) that confirms our ob. er-
vation of inhibition of prostaglandin synthesis by 
gold. 
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